Immobiliere Distri-Land NV (EBR:DISL)

Intra-Cellular Therapies Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Rental Revenue	1.4	1.3	1.22	1.31	1.29
Other Revenue	-	-0	-	-	-
Total Revenue	1.4	1.3	1.22	1.31	1.29
Revenue Growth (YoY	7.71%	6.66%	-6.79%	1.44%	1.93%
Property Expenses	0.25	0.23	0.22	0.21	0.2
Depreciation & Amortization	0.02	0	0	0	0
Other Operating Expenses	-0.03	-0.02	-0	-0.01	-0.02
Total Operating Expenses	0.24	0.21	0.22	0.2	0.18
Operating Income	1.16	1.09	1.01	1.11	1.11
Interest Expense	-1.14	-1.07	-0.97	-1.1	-1.11
Interest & Investment Income	-	-	-	-	0
Other Non-Operating Income	0	0.01	0	-	0.02
EBT Excluding Unusual Items	0.03	0.03	0.04	0.02	0.01
Other Unusual Items	-0.01	-0.01	-0.03	-0	-
Pretax Income	0.01	0.01	0.01	0.01	0.01
Income Tax Expense	0	0	0	0	0
Net Income	0.01	0.01	0.01	0.01	0.01
Net Income to Common	0.01	0.01	0.01	0.01	0.01
Net Income Growth	7.04%	10.91%	-12.13%	8.61%	7.89%
Operating Margin	82.84%	83.63%	82.28%	84.73%	85.92%
Profit Margin	0.67%	0.68%	0.65%	0.69%	0.64%
EBITDA	1.18	1.09	1.01	1.11	1.11
EBITDA Margin	84.24%	83.97%	82.52%	84.96%	86.16%
D&A For Ebitda	0.02	0	0	0	0
EBIT	1.16	1.09	1.01	1.11	1.11
EBIT Margin	82.84%	83.63%	82.28%	84.73%	85.92%
Effective Tax Rate	25.00%	25.51%	24.37%	28.53%	31.15%
Revenue as Reported	1.52	1.41	1.32	1.41	1.4

Updated Mar 1, 2022. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.